Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLC

NCT00319514 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Advanced Non-Small Cell Lung Cancer

Interventions

DRUG: Docetaxel

Sponsor

Gachon University Gil Medical Center